Mobility Device Use and Mobility Disability in U.S. Medicare Beneficiaries With and Without Cancer History
BACKGROUND/OBJECTIVES To examine the prevalence of mobility device use in U.S. community‐dwelling older adults including older adults with cancer history (“survivors”) and to estimate mobility disability noting variation by cancer history, cancer site, and other factors to improve early detection of...
Uložené v:
| Vydané v: | Journal of the American Geriatrics Society (JAGS) Ročník 68; číslo 12; s. 2872 - 2880 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Hoboken, USA
John Wiley & Sons, Inc
01.12.2020
Wiley Subscription Services, Inc |
| Predmet: | |
| ISSN: | 0002-8614, 1532-5415, 1532-5415 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | BACKGROUND/OBJECTIVES
To examine the prevalence of mobility device use in U.S. community‐dwelling older adults including older adults with cancer history (“survivors”) and to estimate mobility disability noting variation by cancer history, cancer site, and other factors to improve early detection of mobility limitations.
DESIGN
Cross‐sectional analysis from the 2011 National Health and Aging Trends Study.
SETTING
In‐person interviews in the homes of study participants.
PARTICIPANTS
Nationally representative sample of community‐dwelling Medicare beneficiaries, aged 65 and older (n = 6,080 including 1,203 survivors).
MEASUREMENTS
Participants were asked about cancer history, pain that limited activity, mobility device use (eg, canes, walkers, wheelchairs, and scooters), history of falls, and medical conditions plus they were assessed for approximate mobility disability using a 3‐m gait speed test. The results were scored on a scale of 0 to 4 (0 = lowest, 4 = highest) using criteria from the National Institute on Aging.
RESULTS
A total of 19% of older adults and 23% of survivors reported using one or more mobility device, most commonly a single‐point cane. Approximately 10% of breast, 6% of prostate, and 3% of colorectal cancer survivors reported using two or more devices in the past month. Survivors had lower mean gait speed scores (2.27) than adults without cancer history (2.39). In regression models, survivors were 18% less likely than adults without cancer history to score high on the gait speed test (odds ratio = .82; P < .05). Prior mobility device use, history of multiple falls, unhealthy weight, Black race, multimorbidity, and pain that limited activity were associated with lower gait speed scores in all participants (all P < .05).
CONCLUSION
A greater proportion of older survivors used mobility devices than adults without cancer history. Mobility device use varied by cancer site and was highest in survivors of breast, colorectal, and gynecological cancer. Survivors were also more likely to show signs of mobility disability, based on gait speed, compared with adults without cancer history. These indications, although modest, suggest that older survivors may require special attention to functional changes in survivorship. |
|---|---|
| Bibliografia: | Portions of this work were previously presented at the 2019 Society of Behavioral Medicine and American Society of Preventive Oncology annual conferences. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 SMB led the conceptualization, design, analysis, and writing of this manuscript. EF assisted with analysis and data management for the study. GC, EF and HDK assisted in interpreting data and writing the manuscript. HDK provided critical clinical expertise in geriatrics and geriatric oncology. AUTHOR CONTRIBUTIONS |
| ISSN: | 0002-8614 1532-5415 1532-5415 |
| DOI: | 10.1111/jgs.16789 |